Possible Alzheimer’s Drug Advancements; Bernard-Henri Lévy On Syria

Possible Alzheimer’s Drug Advancements; Bernard-Henri Lévy On Syria

WBEZ brings you fact-based news and information. Sign up for our newsletters to stay up to date on the stories that matter.
Biotech company Biogen has announced plans to seek experimental approval for an Alzheimer’s drug that appeared to fail in clinical trials earlier this year. STAT reporter Sharon Begley has the latest. Also, French philosopher Bernard-Henri Lévy, a vocal advocate for the Kurds, discusses the recent developments in Syria.